Oric Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oric Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Oric Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.06M, a 30.8% increase year-over-year.
  • Oric Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $18.9M, a 31.2% increase year-over-year.
  • Oric Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15.2M, a 5.3% increase from 2022.
  • Oric Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14.5M, a 12.5% increase from 2021.
  • Oric Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.9M, a 144% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15.2M +$766K +5.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $14.5M +$1.61M +12.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $12.9M +$7.58M +144% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $5.28M +$4.18M +382% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $1.09M +$625K +133% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
2018 $469K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.